title: Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review.
abstract: Dysphagia or swallowing difficulties have been reported to be a concern in adults with multiple sclerosis (MS). This problem can result in several complications including aspiration pneumonia, reduced quality of life and an increase in mortality rate. No previous systematic reviews on treatment effects for dysphagia in MS have been published. The main objective of this study is to summarise and qualitatively analyse published studies on treatment effects for dysphagia in MS. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were applied to conduct a systematic search of seven databases, using relevant key words, and subsequent analysis of the identified studies. The studies were required to meet all three inclusion criteria of including a statement on intention to treat, or measure the effects of treatment for dysphagia in adults with MS and data on treatment outcomes for at least one adult diagnosed with MS. Retained studies were evaluated by two independent reviewers using a critical appraisal tool. This study has not been registered. A total of 563 studies were identified from the database searches. After screening and assessment of full articles for eligibility, five studies were included in the review. Three examined electrical stimulation and two examined the use of botulinum toxin. One study testing electrical stimulation was a randomised controlled trial, two were well-designed case series and two were case series lacking experimental control. All studies reported some positive effects on dysphagia; however, treatments that involved the use of electrical stimulation showed larger effect sizes. There is a paucity of evidence to guide treatment of dysphagia in MS, with only electrical stimulation and botulinum toxin treatment represented in the literature search conducted here. While both treatments show initial promise for reducing the swallowing impairment, they require further research using well-controlled experimental designs to determine their clinical applicability and long-term treatment effects for dysphagia across different types and severity of MS.
authors.affiliation: University of Sydney, FHS/S164, 75 East Street, Lidcombe, NSW, 2141, Australia. dala4451@uni.sydney.edu.au.
authors.forename: Dalal
authors.initials: D
authors.lastname: Alali
authors.affiliation: University of Sydney, FHS, 75 East Street, Lidcombe, NSW, 2141, Australia.
authors.forename: Kirrie
authors.initials: K
authors.lastname: Ballard
authors.affiliation: University of Sydney, FHS/S169, 75 East Street, Lidcombe, NSW, 2141, Australia.
authors.forename: Hans
authors.initials: H
authors.lastname: Bogaardt
mesh_terms: D000328:Adult; D001905:Botulinum Toxins / Q000627:therapeutic use*; D003679:Deglutition / Q000502:physiology; D003680:Deglutition Disorders / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D004599:Electric Stimulation Therapy / Q000379:methods*; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications*; D009498:Neurotoxins / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D009498:Neurotoxins; D001905:Botulinum Toxins
keywords: Deglutition; Dysphagia; Multiple sclerosis; Systematic review; Treatment